Tweenvest Stocks

Yabao Pharmaceutical Group Co., Ltd (SHSE: 600351)

Health Care · Pharmaceuticals · CN

CN¥6.87

-1.43% today · -6.0% 1Y

Yabao Pharmaceutical Group Co., Ltd (SHSE: 600351) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $707.19M and employs 3,415 people.

Over the last twelve months the share price has lost 6.0%, trading between 5.60 and 7.45.

Tweenvest scores Yabao Pharmaceutical Group Co., Ltd across four factors: quality 80/100, value 67/100, growth 43/100, dividend 65/100. Its strongest factor is quality.

600351 price history

Not enough price history to draw a chart yet.

Key figures

Market cap
$707.19M
Revenue (TTM)
$330.59M
P/E
14.76
EPS
0.47
Dividend yield
4.37%
Beta (5Y)
0.02
52-week high
CN¥7.45
52-week low
CN¥5.60
Avg volume (3M)
Shares outstanding
692.00M
Employees
3,415
Next earnings

About Yabao Pharmaceutical Group Co., Ltd

Yabao Pharmaceutical Group Co., Ltd researches, develops, manufactures, and sells Chinese and Western medicines, and pharmaceutical packaging materials in China and internationally. It provides pediatric products, cardiovascular and cerebrovascular products, endocrine products, women's health products, patches, and general health products. Yabao Pharmaceutical Group Co., Ltd was founded in 1978 and is based in Beijing, China.

ISIN
CNE000001CM5
Founded
1978
Listed since
Sep 26, 2002
Exchange
Shanghai Stock Exchange
Currency
CNY
CompanyMarket capPriceDay
Eli Lilly and CompanyNYSE: LLY$1.06T$1,189.41-3.59%
Johnson & JohnsonNYSE: JNJ$650.67B$270.00-1.15%
Merck & Co., Inc.NYSE: MRK$377.72B$153.10-2.14%
Roche Holding AGSWX: ROP$365.10BCHF368.30-1.47%
Novartis AGSWX: NOVN$300.07BCHF127.18-0.90%
AstraZeneca PLCLSE: AZN$257.89B£122.34-1.94%
Novo Nordisk A/SCPSE: NOVO B$210.23BDkr304.95-0.93%
Pfizer Inc.NYSE: PFE$161.30B$28.30-0.95%

Browse every Pharmaceuticals company →

Figures last refreshed Aug 18, 2026.